Monash IVF Group Limited (MNIVF)

OTCMKTS · Delayed Price · Currency is USD
0.4000
-0.1100 (-21.57%)
At close: Jun 10, 2025
Market Cap197.42M +0.6%
Revenue (ttm)179.69M -0.1%
Net Income10.11M
EPS0.03
Shares Out n/a
PE Ratio19.53
Forward PE13.47
Dividendn/a
Ex-Dividend Daten/a
Volume48,000
Open0.4000
Previous Close0.5100
Day's Range0.4000 - 0.4000
52-Week Range0.4000 - 0.7400
Beta0.40
Analystsn/a
Price Targetn/a
Earnings DateAug 24, 2026

About Monash IVF Group

Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Australia. [Read more]

Sector Healthcare
Founded 2014
Employees 892
Stock Exchange OTCMKTS
Ticker Symbol MNIVF

Financial Performance

Financial numbers in AUD Financial Statements

News

Monash IVF Group Earnings Call Transcript: H1 2026

Underlying NPAT reached AUD 10.4 million at the upper end of guidance, despite revenue and market share declines in domestic IVF. International and genetics segments showed growth, and margin recovery is targeted through price increases and operational efficiencies into FY 2027.

3 months ago - Transcripts

Monash IVF Group Quarterly report: H1 2026

Monash IVF Group has published its H1 2026 quarterly earnings report on February 25, 2026.

3 months ago - Filings

Monash IVF Group Slides: H1 2026

Monash IVF Group has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 25, 2026.

3 months ago - Filings

Monash IVF Group Transcript: AGM 2025

Revenue and EBITDA grew in FY2025 despite sector headwinds and adverse incidents, with no final dividend declared. Board renewal and leadership transition are underway, and strategic investments continue, while competitive pressures and risk management remain key focus areas.

7 months ago - Transcripts

Monash IVF Group Slides: FY 2025

Monash IVF Group has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 19, 2025.

7 months ago - Filings

Monash IVF Group Earnings Call Transcript: H2 2025

Underlying NPAT for FY2025 was AUD 27.4 million, with revenue up 7% and EBITDA up 5.6%, despite market share declines and industry headwinds. FY2026 guidance is for lower NPAT due to a 10% drop in new patient registrations, but mid-single-digit growth is expected to resume from FY2027.

10 months ago - Transcripts

Monash IVF Group Annual report: H2 2025

Monash IVF Group has published its H2 2025 annual report on August 21, 2025.

10 months ago - Filings

Monash IVF Group Slides: H2 2025

Monash IVF Group has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 21, 2025.

10 months ago - Filings